Domestic cold remedy makers rushing to recall PPA-containing preparations

Published: 2004-08-09 07:00:00

Updated: 2004-08-09 07:00:00

With the recent announcement of the Korea Food and Drug Administration that it has banned production and sales of 167 cough and cold remedies containing phenylpropanolamine (PPA), an ingredient that may cause hemorrhagic strokes, 75 pharmaceutical manufactures are rapidly rushing to remove PPA-co...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK